XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.350
-0.215 (-8.38%)
At close: Jun 26, 2026, 4:00 PM EDT
2.360
+0.010 (0.43%)
After-hours: Jun 26, 2026, 4:10 PM EDT
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
$96,800
Profits / Employee
-$630,800
Market Cap
5.68M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% |
| Dec 31, 2016 | 7 | 1 | 16.67% |
| Dec 31, 2015 | 6 | 1 | 20.00% |
| Dec 31, 2014 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| NextCure | 40 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| Purple Biotech | 10 |
| CNS Pharmaceuticals | 8 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
XTLB News
- 5 weeks ago - XTL Biopharmaceuticals (XTLB) Faces Nasdaq Compliance Challenges Amid Stock Surge - GuruFocus
- 5 weeks ago - XTL Announces Receipt of Staff Delist Determination from Nasdaq - GlobeNewsWire
- 2 months ago - 3 Penny Stocks to Watch Now, 4/30/26 - TipRanks
- 2 months ago - XTL Biopharmaceuticals (XTLB) to Acquire Psyga Bio, Shares Surge 58.7% - GuruFocus
- 2 months ago - XTL Biopharmaceuticals to acquire Psyga Bio - TheFly
- 2 months ago - XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies - GlobeNewsWire
- 3 months ago - XTL Biopharmaceuticals trading halted, news pending - TheFly
- 3 months ago - XTL Biopharmaceuticals (XTLB) Adjusts ADS to Ordinary Share Ratio - GuruFocus